Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aung Naing

Showing results (181-190 of 397) with videos related to

Pageof 40
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2011
Phase I trial of cixutumumab combined with temsirolimus in patients with advanced cancerAung Naing, Razelle Kurzrock, Angelika Burger, et al.
Investigational New Drugs|April 26, 2014
Evaluation of a novel blood pressure scoring method and its association with clinical response in cancer patients treated with anti-vascular endothelial growth factor therapyMehmet Asim Bilen, Jean-Bernard Durand, Lacey McQuinn, et al.
Journal for Immunotherapy of Cancer|December 20, 2017
Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trialsRoman Groisberg, David S Hong, Amini Behrang, et al.
The American Journal of Gastroenterology|November 10, 2018
Sofosbuvir-Based Therapy in Hepatitis C Virus-Infected Cancer Patients: A Prospective Observational StudyHarrys A Torres, Minas P Economides, Georgios Angelidakis, et al.
Investigational New Drugs|January 8, 2021
The clinical efficacy and safety of single-agent pembrolizumab in patients with recurrent granulosa cell tumors of the ovary: a case series from a phase II basket trialJeffrey A How, Amir Jazaeri, Shannon N Westin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2011
A phase 1 dose escalation, pharmacokinetic, and pharmacodynamic evaluation of eIF-4E antisense oligonucleotide LY2275796 in patients with advanced cancerDavid S Hong, Razelle Kurzrock, Yun Oh, et al.
Tropical Medicine and Infectious Disease|April 27, 2026
Series 3: From Infection to Disease: A Global Scoping Review of Medical and Behavioural Determinants of Progression from TB Infection to TB DiseaseSonia Menon, Anthony D Harries, Riitta A Dlodlo, et al.
Tropical Medicine and Infectious Disease|February 26, 2026
Series 1: Behind the Spread: A Scoping Review of Risk Factors for Exposure to <i>Mycobacterium tuberculosis</i>Sonia Menon, Anthony D Harries, Riitta A Dlodlo, et al.
Cancer Chemotherapy and Pharmacology|November 13, 2012
Dose-finding study of hepatic arterial infusion of oxaliplatin-based treatment in patients with advanced solid tumors metastatic to the liverApostolia M Tsimberidou, Mark B Leick, Joann Lim, et al.
Cancer Research|October 16, 2012
PIK3CA mutation H1047R is associated with response to PI3K/AKT/mTOR signaling pathway inhibitors in early-phase clinical trialsFilip Janku, Jennifer J Wheler, Aung Naing, et al.
Pageof 40

Showing results (181-190 of 397) with videos related to

Sort By:
Pageof 40
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2011
Phase I trial of cixutumumab combined with temsirolimus in patients with advanced cancerAung Naing, Razelle Kurzrock, Angelika Burger, et al.
Investigational New Drugs|April 26, 2014
Evaluation of a novel blood pressure scoring method and its association with clinical response in cancer patients treated with anti-vascular endothelial growth factor therapyMehmet Asim Bilen, Jean-Bernard Durand, Lacey McQuinn, et al.
Journal for Immunotherapy of Cancer|December 20, 2017
Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trialsRoman Groisberg, David S Hong, Amini Behrang, et al.
The American Journal of Gastroenterology|November 10, 2018
Sofosbuvir-Based Therapy in Hepatitis C Virus-Infected Cancer Patients: A Prospective Observational StudyHarrys A Torres, Minas P Economides, Georgios Angelidakis, et al.
Investigational New Drugs|January 8, 2021
The clinical efficacy and safety of single-agent pembrolizumab in patients with recurrent granulosa cell tumors of the ovary: a case series from a phase II basket trialJeffrey A How, Amir Jazaeri, Shannon N Westin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2011
A phase 1 dose escalation, pharmacokinetic, and pharmacodynamic evaluation of eIF-4E antisense oligonucleotide LY2275796 in patients with advanced cancerDavid S Hong, Razelle Kurzrock, Yun Oh, et al.
Tropical Medicine and Infectious Disease|April 27, 2026
Series 3: From Infection to Disease: A Global Scoping Review of Medical and Behavioural Determinants of Progression from TB Infection to TB DiseaseSonia Menon, Anthony D Harries, Riitta A Dlodlo, et al.
Tropical Medicine and Infectious Disease|February 26, 2026
Series 1: Behind the Spread: A Scoping Review of Risk Factors for Exposure to <i>Mycobacterium tuberculosis</i>Sonia Menon, Anthony D Harries, Riitta A Dlodlo, et al.
Cancer Chemotherapy and Pharmacology|November 13, 2012
Dose-finding study of hepatic arterial infusion of oxaliplatin-based treatment in patients with advanced solid tumors metastatic to the liverApostolia M Tsimberidou, Mark B Leick, Joann Lim, et al.
Cancer Research|October 16, 2012
PIK3CA mutation H1047R is associated with response to PI3K/AKT/mTOR signaling pathway inhibitors in early-phase clinical trialsFilip Janku, Jennifer J Wheler, Aung Naing, et al.
Pageof 40